Cerebral sinus thrombosis and oral contraceptives. There are limits to predictability.
作者信息
Vandenbroucke J P
出版信息
BMJ. 1998 Aug 22;317(7157):483-4. doi: 10.1136/bmj.317.7157.483.
Abstract
摘要
相似文献
1
Cerebral sinus thrombosis and oral contraceptives. There are limits to predictability.脑静脉窦血栓形成与口服避孕药。预测存在局限性。
BMJ. 1998 Aug 22;317(7157):483-4. doi: 10.1136/bmj.317.7157.483.
2
Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group.口服避孕药使用者及遗传性血栓形成倾向携带者发生脑静脉窦血栓形成风险的病例对照研究。脑静脉窦血栓形成研究组。
BMJ. 1998 Feb 21;316(7131):589-92. doi: 10.1136/bmj.316.7131.589.
3
Oral contraceptives and cerebral venous thrombosis: case report and a brief review of literature.口服避孕药与脑静脉血栓形成：病例报告及文献简要综述
J Pak Med Assoc. 2006 Nov;56(11):559-61.
4
Cerebral venous sinus thrombosis with ophthalmic manifestations in 18-year-olds on oral contraceptives.18岁口服避孕药女性发生伴有眼部表现的脑静脉窦血栓形成
Clin Pediatr (Phila). 2014 Aug;53(9):826-30. doi: 10.1177/0009922814533405. Epub 2014 May 6.
5
Low-oestrogen oral contraceptives as a major risk factor for cerebral venous and sinus thrombosis: evidence from a clinical series.低雌激素口服避孕药作为脑静脉和窦血栓形成的主要危险因素：来自临床系列研究的证据
Ital J Neurol Sci. 1999 Aug;20(4):231-5. doi: 10.1007/s100720050036.
6
[Causal relationship between the use of oral contraceptives and neurological complications? Presentation of a case of extensive cerebral vein thrombosis].
Munch Med Wochenschr. 1967 Mar 31;109(13):691-8.
7
Sagittal sinus thrombosis related to oral contraceptives. Case report.
J Neurosurg. 1970 Dec;33(6):714-7. doi: 10.3171/jns.1970.33.6.0714.
8
Cerebral arterial occlusion and intracranial venous thrombosis in a woman taking oral contraceptives.一名服用口服避孕药的女性发生脑动脉闭塞和颅内静脉血栓形成。
Postgrad Med J. 1984 Jun;60(704):426-8. doi: 10.1136/pgmj.60.704.426.
9
[Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].
Dtsch Med Wochenschr. 1998 Feb 6;123(6):137-9. doi: 10.1055/s-2007-1023917.
10
Hereditary protein S deficiency presenting with cerebral sinus thrombosis in an adolescent girl.
J Neurol. 1992 Feb;239(2):105-6. doi: 10.1007/BF00862984.
引用本文的文献
1
Rare Presentation of Cerebral Venous Sinus Thrombosis in a Child.儿童脑静脉窦血栓形成的罕见表现
J Pediatr Neurosci. 2017 Oct-Dec;12(4):389-392. doi: 10.4103/jpn.JPN_109_17.
2
Cerebral venous thrombosis: role of CT, MRI and MRA in the emergency setting.脑静脉血栓形成：急诊中 CT、MRI 和 MRA 的作用。
Radiol Med. 2010 Mar;115(2):313-25. doi: 10.1007/s11547-010-0493-4. Epub 2010 Jan 20.
3
Cerebral venous sinus thrombosis.脑静脉窦血栓形成
Postgrad Med J. 2000 Jan;76(891):12-5. doi: 10.1136/pmj.76.891.12.
本文引用的文献
1
Science, medicine, and the future: assessing thrombotic risk.
BMJ. 1998 Aug 22;317(7157):520-3. doi: 10.1136/bmj.317.7157.520.
2
Venous thrombosis--the interaction of genes and environment.
N Engl J Med. 1998 Jun 18;338(25):1840-1. doi: 10.1056/NEJM199806183382510.
3
High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.凝血酶原基因突变携带者及口服避孕药使用者发生脑静脉血栓形成的风险较高。
N Engl J Med. 1998 Jun 18;338(25):1793-7. doi: 10.1056/NEJM199806183382502.
4
Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group.口服避孕药使用者及遗传性血栓形成倾向携带者发生脑静脉窦血栓形成风险的病例对照研究。脑静脉窦血栓形成研究组。
BMJ. 1998 Feb 21;316(7131):589-92. doi: 10.1136/bmj.316.7131.589.
5
Acquired APC resistance related to oral contraceptives and pregnancy and its possible implications for clinical practice.
Blood Coagul Fibrinolysis. 1997 Mar;8(2):152-4. doi: 10.1097/00001721-199703000-00011.
6
Oral contraceptives and venous thromboembolism.
Lancet. 1997 May 31;349(9065):1623. doi: 10.1016/S0140-6736(05)61660-1.
7
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.口服避孕药与静脉血栓形成：使用第二代和第三代口服避孕药的女性对活化蛋白C的敏感性不同。
Br J Haematol. 1997 Apr;97(1):233-8. doi: 10.1046/j.1365-2141.1997.192707.x.
8
Factor V Leiden: should we screen oral contraceptive users and pregnant women?凝血因子V莱顿突变：我们应该对口服避孕药使用者和孕妇进行筛查吗？
BMJ. 1996 Nov 2;313(7065):1127-30. doi: 10.1136/bmj.313.7065.1127.
9
[Public health economic evaluation of screening for APC resistance (Leiden mutation) in new oral contraceptive users].
Med Klin (Munich). 1996 May 15;91(5):317-9.
10
Apolipoproteins and ischaemic heart disease: implications for screening.
Lancet. 1994 Jan 8;343(8889):75-9. doi: 10.1016/s0140-6736(94)90814-1.
Zotero 插件